Vigilant Diagnostics LLC

Vigilant Diagnostics lets healthcare providers conduct diagnostic tests in any point-of-care setting. Founded in 2014, we are a spinout of the University of Minnesota Office for Technology Commercialization. We hold worldwide patents for a Lateral Flow Assay (LFA) technology called "Thermal Contrast Amplification" (TCA). It is designed to be used in a cost-effective, easy-to-use reader device we designed and are now making available to strategic partners. (See it on our website.) Our technology features industry-leading test sensitivity approaching that of expensive, time-consuming laboratory tests. For more information, please email us at [email protected]. We'd love to hear from you!

网站

https://VigilantDX.com

Vigilant Diagnostics LLC的外部链接

所属行业

生物技术研究

规模

2-10 人

总部

Minneapolis，MN

类型

私人持股

创立

2014

领域

Infectious Diseases、Point-of-Care Diagnostics、Thermal Contrast Technology、Lateral Flow Assays (LFAs)、LFA Readers、At-Home Testing、COVID-19、HIV、Malaria、Strep和Influenza